Glioblastoma in adults, Critical Reviews in Oncology/Hematology, vol.67, issue.2, pp.139-52, 2008. ,
DOI : 10.1016/j.critrevonc.2008.02.005
Histological classification of human gliomas: state of art and controversies], Bull Cancer, vol.92, issue.4, pp.301-310, 2005. ,
Perspectives in diagnosis and management of malignant gliomas]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.6-7695, 2008. ,
[A practical guide for the management of gliomas]. Bull Cancer (Paris), pp.817-839, 2007. ,
Therapeutic strategies for the management of gliomas], Rev Neurol, vol.164, pp.6-7523, 2008. ,
Assessment and treatment relevance in elderly glioblastoma patients. Neuro-Oncol, 2014. ,
The epidemiology of glioma in adults: a " state of the science " review. Neuro-Oncol, 2014. ,
Primary Gliosarcoma of the Brain: Radiologic and Histopathologic Features, The Neuroradiology Journal, vol.83, issue.1, pp.639-687, 2013. ,
DOI : 10.1007/s11060-006-9295-x
The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007. ,
DOI : 10.1093/jnen/60.9.863
Gliomas: WHO and Sainte-Anne Hospital classifications], Ann Pathol, vol.20, issue.5, pp.413-441, 2000. ,
Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases, J Neurooncol, 1997. ,
Part II: A new grading system based on morphological and imaging criteria, Journal of Neuro-Oncology, vol.34, issue.1, pp.61-78, 1997. ,
DOI : 10.1023/A:1005759220434
Overexpression of N-ras Oncogene and Epidermal Growth Factor Receptor Gene in Human Glioblastomas, JNCI Journal of the National Cancer Institute, vol.81, issue.1, pp.63-70, 1989. ,
DOI : 10.1093/jnci/81.1.63
Oncogenes and growth factors in gliomas, J Neurosurg Sci, vol.34, pp.3-4171, 1990. ,
Genetic pathways to glioblastomas, Neuropathol Off J Jpn Soc Neuropathol, vol.25, issue.1, pp.1-7, 2005. ,
DOI : 10.1111/j.1440-1789.2004.00600.x
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA, Proceedings of the National Academy of Sciences, vol.111, issue.9 ,
DOI : 10.1073/pnas.0506580102
Clonal expansion of p53 mutant cells is associated with brain tumour
progression, Nature, vol.355, issue.6363, pp.846-853, 1992. ,
DOI : 10.1038/355846a0
p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression, Cancer Res. Feb, vol.152, issue.3, pp.674-683, 1992. ,
Analysis of p53 Mutation and Epidermal Growth Factor Receptor Amplification in Recurrent Gliomas with Malignant Progression, Journal of Neuropathology and Experimental Neurology, vol.55, issue.7, 1996. ,
DOI : 10.1097/00005072-199607000-00007
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated, Cancer Res, vol.56, issue.1, pp.150-153, 1996. ,
Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas, Neuropathology and Applied Neurobiology, vol.22, issue.5, 1998. ,
DOI : 10.1023/A:1005841520514
A Changing Paradigm of Glioma Biology, Hematology/Oncology Clinics of North America, vol.20, issue.6, pp.1171-91, 2006. ,
DOI : 10.1016/j.hoc.2006.09.010
Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours, British Journal of Cancer, vol.75, issue.1, pp.2-8, 1997. ,
DOI : 10.1038/bjc.1997.2
Mutational analysis of thePTEN gene in gliomas: Molecular and pathological correlations, International Journal of Cancer, vol.15, issue.2, pp.150-154, 1999. ,
DOI : 10.1038/sj.onc.1201337
p14ARF Deletion and Methylation in Genetic Pathways to Glioblastomas, Brain Pathology, vol.18, issue.2, pp.159-68, 2001. ,
DOI : 10.1038/bjc.1997.2
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells, Scientific Reports, vol.19, issue.1, p.9956, 2015. ,
DOI : 10.1016/S0304-3959(02)00041-6
Hydroxyurea accelerates the loss of epidermal growth factor receptor genes amplified as double-minute chromosomes in human glioblastoma multiforme, Neurosurgery, vol.39, issue.5, pp.976-83, 1996. ,
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group, Clin Cancer Res Off J Am Assoc Cancer Res, vol.16, issue.5, pp.1597-604, 2010. ,
A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer, pp.2798-806, 2005. ,
The impact of age and gender on the incidence of glial tumors in New York state from 1976???1995, Journal of Neurosurgery, vol.93, issue.6, pp.932-941, 2000. ,
DOI : 10.3171/jns.2000.93.6.0932
Racial/ethnic differences in survival among elderly patients with a primary glioblastoma, J Neurooncol. Kitahara CM, vol.85, issue.2, pp.171-80, 2007. ,
Description of selected characteristics of familial glioma patients ??? Results from the Gliogene Consortium, European Journal of Cancer, vol.49, issue.6, pp.1335-1380, 1990. ,
DOI : 10.1016/j.ejca.2012.11.009
Exploring the association between melanoma and glioma risks, Annals of Epidemiology, vol.24, issue.6, p.2014 ,
DOI : 10.1016/j.annepidem.2014.02.010
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111084/pdf
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res, Jul, vol.1565, issue.14, pp.6459-65, 2005. ,
DOI : 10.1158/0008-5472.can-04-3728
URL : http://cancerres.aacrjournals.org/content/canres/65/14/6459.full.pdf
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res, Mar, vol.166, issue.5, pp.2878-2878, 2006. ,
Polymorphisms in the Interleukin-4 Receptor Gene are Associated with Better Survival in Patients with Glioblastoma, Clinical Cancer Research, vol.14, issue.20, pp.6640-6646, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-4681
IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide era, International Journal of Cancer, vol.152, issue.3, pp.680-687, 2009. ,
DOI : 10.1002/ijc.24369
Glioblastoma Invasion, Cathepsin B, and the Potential for Both to be Inhibited by Auranofin, an Old Anti-Rheumatoid Arthritis Drug, Central European Neurosurgery, vol.71, issue.03, pp.139-181, 2010. ,
DOI : 10.1055/s-0029-1242756
Epidemiology of primary brain tumor] Rev Neurol (Paris) Prevalence of glioblastoma multiforme subjects with prior herbicide exposure, J Neurosci Nurs J Am Assoc Neurosci Nurses, vol.1658924, issue.465, pp.650-70260, 1992. ,
A cohort mortality study of petrochemical workers, J Occup Med Off Publ Ind Med Assoc, vol.25, issue.4, pp.304-316, 1983. ,
Discovering gene???environment interactions in Glioblastoma through a comprehensive data integration bioinformatics method, NeuroToxicology, vol.35, pp.1-14 ,
DOI : 10.1016/j.neuro.2012.11.001
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in, Neuro-Oncol, vol.16, issue.4, pp.1-63, 2007. ,
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma ,
DOI : 10.1056/nejmoa043330
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-66, 2003. ,
DOI : 10.1016/S1470-2045(09)70025-7
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network, Journal of Clinical Oncology, vol.27, issue.34, pp.5743-50, 2009. ,
DOI : 10.1200/JCO.2009.23.0805
Prognostic significance of preoperative MRI scans in glioblastoma multiforme, Journal of Neuro-Oncology, vol.126, issue.3, 1996. ,
DOI : 10.1007/BF00146086
Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical Model, Cancer Research, vol.69, issue.23, pp.9133-9173, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-3863
Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival, Surg Neurol Int, vol.1, 2010. ,
Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro-Oncol, Kelly PJ, vol.58, 2015. ,
DOI : 10.1093/neuonc/nov127
URL : https://academic.oup.com/neuro-oncology/article-pdf/18/3/417/7640370/nov127.pdf
Computed tomography and histologic limits in glial neoplasms: Tumor types and selection for volumetric resection, Surgical Neurology, vol.39, issue.6, pp.458-65, 1993. ,
DOI : 10.1016/0090-3019(93)90031-U
Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma, Cancer Research, vol.74, issue.17, pp.4622-4659, 2014. ,
DOI : 10.1158/0008-5472.CAN-14-0383
Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro-Oncol, 2013. ,
Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI, Journal of Neuro-Oncology, vol.7, issue.1, pp.207-221, 2014. ,
DOI : 10.2217/pme.09.49
MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set, Radiology, vol.267, issue.2, pp.560-569, 2013. ,
DOI : 10.1148/radiol.13120118
Computer-extracted MR imaging features are associated with survival in glioblastoma patients, Journal of Neuro-Oncology, vol.41, issue.4, pp.483-491, 2014. ,
DOI : 10.1118/1.4866218
Patientspecific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study, PloS One. Acta Neurochir, vol.9148, issue.285, pp.277-85, 2006. ,
Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study, American Journal of Neuroradiology, vol.239, issue.3, pp.1505-1515, 2008. ,
DOI : 10.1148/radiol.2393042031
gene in cancer, Biochemistry and Cell Biology, vol.137, issue.4, pp.429-466, 2005. ,
DOI : 10.1093/jb/mvi048
Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy. Cancer Lett, Feb, vol.28233, issue.2, pp.195-207, 2006. ,
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected, Molecular Cancer, vol.10, issue.1, p.128, 2011. ,
DOI : 10.1038/nature07567
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy, British Journal of Cancer, vol.33, issue.1, pp.124-155, 2009. ,
DOI : 10.1097/nen.0b013e31815f65fb
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide, Journal of Neuro-Oncology, vol.16, issue.18, pp.311-317, 2011. ,
DOI : 10.1007/s11060-006-9241-y
MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study, International Journal of Radiation Oncology*Biology*Physics, vol.84, issue.3, pp.661-668, 2012. ,
DOI : 10.1016/j.ijrobp.2011.12.086
Oncometabolite 2- hydroxyglutarate is a competitive inhibitor of ?-ketoglutarate-dependent dioxygenases. Cancer Cell, pp.17-30, 2011. ,
IDH mutations in glioma and acute myeloid leukemia, Trends in Molecular Medicine, vol.16, issue.9, pp.387-97, 2010. ,
DOI : 10.1016/j.molmed.2010.07.002
Cellular Defense against UVB-Induced Phototoxicity by Cytosolic NADP+-Dependent Isocitrate Dehydrogenase, Biochemical and Biophysical Research Communications, vol.292, issue.2, pp.542-551, 2002. ,
DOI : 10.1006/bbrc.2002.6667
Multiple NADPH-producing pathways control glutathione (GSH) content in retina, Experimental Eye Research, vol.43, issue.5, pp.829-876, 1986. ,
DOI : 10.1016/S0014-4835(86)80013-6
Redox mechanisms in hepatic chronic wound healing and fibrogenesis An integrated genomic analysis of human glioblastoma multiforme, Fibrogenesis Tissue Repair. Science, vol.1, issue.1, 2008. ,
IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?, The Oncologist, vol.15, issue.2, pp.196-205, 2010. ,
DOI : 10.1634/theoncologist.2009-0218
Analysis of the IDH1 codon 132 mutation in brain tumors, Acta Neuropathologica, vol.6, issue.6, pp.597-602, 2008. ,
DOI : 10.1093/jnen/59.6.544
) occur frequently in high-grade gliomas but not in other solid tumors, Human Mutation, vol.279, issue.1, pp.7-11, 2009. ,
DOI : 10.1016/B978-0-12-152827-0.50009-8
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas, Journal of Clinical Oncology, vol.27, issue.25, pp.4150-4154, 2009. ,
DOI : 10.1200/JCO.2009.21.9832
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas, The American Journal of Pathology, vol.174, issue.4, pp.1149-53, 2009. ,
DOI : 10.2353/ajpath.2009.080958
IDH1 and IDH2 mutations in gliomas, N Engl J Med Feb, vol.19360, issue.8, pp.765-73, 2009. ,
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers, International Journal of Cancer, vol.279, issue.2, pp.353-358, 2009. ,
DOI : 10.1042/bj1180253
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell, pp.225-259, 2010. ,
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.50, issue.7274, pp.739-783, 2009. ,
DOI : 10.1038/nature08617
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation, Tumor Biology, vol.42, issue.3, 2014. ,
DOI : 10.1093/ilar.42.3.189
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1??, Science, vol.12, issue.19-20, pp.261-266, 2009. ,
DOI : 10.1016/j.drudis.2007.08.006
IDH1 mutations in gliomas: when an enzyme loses its grip. Cancer Cell, pp.7-9, 2010. ,
IDH mutation impairs histone demethylation and results in a block to cell differentiation, Nature, vol.249, issue.7390, pp.474-482, 2012. ,
DOI : 10.1006/excr.1999.4434
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, vol.25, issue.7390, pp.479-83, 2012. ,
DOI : 10.1634/stemcells.2007-0040
Glutamate neurotoxicity and diseases of the nervous system, Neuron, vol.1, issue.8, pp.623-657, 1988. ,
DOI : 10.1016/0896-6273(88)90162-6
Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C, Journal of Neurochemistry, vol.16, issue.3, pp.504-519, 2002. ,
DOI : 10.1007/978-1-4757-9551-6_14
A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol Lond Engl, p.95, 2014. ,
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study, Annals of Neurology, vol.12, issue.2, pp.183-191, 1999. ,
DOI : 10.1038/bjc.1992.273
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors, Clin Cancer Res Off J Am Assoc Cancer Res, vol.8, issue.1, pp.180-187, 2002. ,
Long-term survival with glioblastoma multiforme, Brain, vol.130, issue.10, pp.2596-606, 2007. ,
DOI : 10.1093/brain/awm204
URL : https://academic.oup.com/brain/article-pdf/130/10/2596/1070518/awm204.pdf
A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapy, Neuropathology, vol.80, issue.5, pp.576-81, 2013. ,
DOI : 10.3171/jns.1994.80.3.0422
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?, The Lancet Oncology, vol.12, issue.1, pp.83-91, 2011. ,
DOI : 10.1016/S1470-2045(10)70053-X
Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations, Clinical Cancer Research, vol.19, issue.18, pp.5146-57, 2013. ,
DOI : 10.1158/1078-0432.CCR-13-0017
URL : http://clincancerres.aacrjournals.org/content/clincanres/19/18/5146.full.pdf
Long-term survival in primary glioblastoma revisited: The contribution of isocitrate dehydrogenase mutations, Neuropathology J Clin Oncol, vol.31, issue.2027, p.2013 ,
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation, Neurology, vol.81, issue.17, pp.1515-1537, 2013. ,
DOI : 10.1212/WNL.0b013e3182a95680
Transcriptional diversity of long-term glioblastoma survivors. Neuro-Oncol, pp.1186-95, 2014. ,
DOI : 10.1093/neuonc/nou043
URL : https://academic.oup.com/neuro-oncology/article-pdf/16/9/1186/7639959/nou043.pdf
The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere, Surgical Neurology, vol.52, issue.4, pp.371-380, 1999. ,
DOI : 10.1016/S0090-3019(99)00103-2
Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection, Journal of Neurosurgery, vol.114, issue.3, pp.604-616, 2011. ,
DOI : 10.3171/2010.4.JNS091340
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725949/pdf
Conclusion:, The Canadian Journal of Neurological Sciences, vol.26, issue.05, pp.632-639, 2012. ,
DOI : 10.3171/jns.2001.95.2.0190
Multiple resections for patients with glioblastoma: prolonging survival, Journal of Neurosurgery, vol.118, issue.4, pp.812-832 ,
DOI : 10.3171/2012.9.JNS1277
URL : http://thejns.org/doi/pdf/10.3171/2012.9.JNS1277
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3, The Lancet Oncology, vol.9, issue.1, pp.29-38, 2008. ,
DOI : 10.1016/S1470-2045(07)70384-4
Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery, New England Journal of Medicine, vol.303, issue.23, pp.1323-1332, 1980. ,
DOI : 10.1056/NEJM198012043032303
Radiotherapy for Glioblastoma in the Elderly, New England Journal of Medicine, vol.356, issue.15, pp.1527-1562, 2007. ,
DOI : 10.1056/NEJMoa065901
Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution, Radiation Oncology, vol.190, issue.10, p.106, 2015. ,
DOI : 10.1007/s00066-014-0638-9
Radiotherapy for glioblastomas: from radiobiology to concomitant chemotherapy]. Cancer Radiothérapie J Société Fr Radiothérapie Oncol, pp.322-353, 2005. ,
Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma, Clinical Cancer Research, vol.20, issue.19, pp.5023-5054, 2014. ,
DOI : 10.1158/1078-0432.CCR-14-0822
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme, Cancer, vol.16, issue.2, pp.355-61, 1998. ,
DOI : 10.1016/0360-3016(89)90941-3
Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394, Journal of Clinical Oncology, vol.21, issue.8, pp.1485-91, 2003. ,
DOI : 10.1200/JCO.2003.10.035
Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.4, pp.1147-55, 2010. ,
DOI : 10.1016/j.ijrobp.2009.09.018
BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors, BMC Cancer, vol.52, issue.1, p.30, 2010. ,
DOI : 10.1023/A:1010624504311
URL : http://doi.org/10.1186/1471-2407-10-30
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, vol.362, issue.6423, pp.841-845, 1993. ,
DOI : 10.1038/362841a0
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme, Journal of Clinical Oncology, vol.29, issue.2, pp.142-150, 2011. ,
DOI : 10.1200/JCO.2010.30.2729
ASCO 2013: bevacizumab and glioblastoma ??? a marriage dissolution?, Current Medical Research and Opinion, vol.30, issue.9, pp.1871-1874, 2014. ,
DOI : 10.1185/03007995.2014.921145
URL : http://www.tandfonline.com/doi/pdf/10.1185/03007995.2014.921145?needAccess=true
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma, Journal of Clinical Oncology, vol.33, issue.19, 2015. ,
DOI : 10.1200/JCO.2014.60.3217
Molecular profiling in glioblastoma: Prelude to personalized treatment, Current Oncology Reports, vol.14, issue.Suppl, pp.53-61, 2009. ,
DOI : 10.1016/S0002-9440(10)61750-6
Effect of TNFRSF6B neutralization antibody on cell growth suppression and apoptosis induction in glioma cells, Neoplasma, vol.62, issue.04, 2015. ,
DOI : 10.4149/neo_2015_069
EGFR blockade prevents glioma escape from BRAFV600E targeted therapy, Oncotarget, 2015. ,
DOI : 10.18632/oncotarget.4014
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=4014&path%5B%5D=10562
NFKBIA deletion in glioblastomas, N Engl J Med Feb, vol.17364, issue.7, pp.627-664, 2011. ,
Development of anin vitro extracellular matrix assay for studies of brain tumor cell invasion, Journal of Neuro-Oncology, vol.16, issue.1, pp.1-15, 1994. ,
DOI : 10.1016/B978-0-12-695680-1.50017-X
A screening platform for glioma growth and invasion using bioluminescence imaging, Journal of Neurosurgery, vol.111, issue.2, pp.238-284, 2009. ,
DOI : 10.3171/2008.8.JNS08644
Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index, Neuroradiology, vol.46, issue.2, 2015. ,
DOI : 10.1097/RLI.0b013e31821eea45
Correlation of in vitro infiltration with glioma histological type in organotypic brain slices, British Journal of Cancer, vol.103, issue.4, pp.745-52, 2004. ,
DOI : 10.1007/s004010100464
Toward 3D Biomimetic Models to Understand the Behavior of Glioblastoma Multiforme Cells, Tissue Engineering Part B: Reviews, vol.20, issue.4, pp.314-341, 2014. ,
DOI : 10.1089/ten.teb.2013.0227
A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth, Cell Proliferation, vol.32, issue.1, pp.17-31, 1995. ,
DOI : 10.1001/archneur.1975.00490530053004
A mathematical model of glioma growth: the effect of extent of surgical resection, Cell Proliferation, vol.28, issue.6, pp.269-88, 1996. ,
DOI : 10.1007/978-3-662-08539-4
The Interaction of Growth Rates and Diffusion Coefficients in a Three-dimensional Mathematical Model of Gliomas, Journal of Neuropathology and Experimental Neurology, vol.56, issue.6, pp.704-717, 1997. ,
DOI : 10.1097/00005072-199706000-00008
Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy, British Journal of Cancer, vol.29, issue.1, pp.14-22, 2002. ,
DOI : 10.1111/j.1365-2184.1996.tb01580.x
Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion, Journal of the Neurological Sciences, vol.216, issue.1, pp.1-10, 2003. ,
DOI : 10.1016/j.jns.2003.06.001
Deformable Registration of Glioma Images Using EM Algorithm and Diffusion Reaction Modeling, IEEE Transactions on Medical Imaging, vol.30, issue.2, pp.375-90, 2011. ,
DOI : 10.1109/TMI.2010.2078833
A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle, British Journal of Cancer, vol.170, issue.1, pp.113-122, 2008. ,
DOI : 10.1002/(SICI)1096-9098(199912)72:4<199::AID-JSO4>3.0.CO;2-O
Inter- and intrapatients comparison of WHO grade II glioma kinetics before and after surgical resection, Neurosurgical Review, vol.26, issue.8, pp.91-97, 2010. ,
DOI : 10.1007/s10143-009-0229-x
URL : https://hal.archives-ouvertes.fr/hal-00492516
Co-Planar stereotaxic Atlas of the human brain, 1988. ,
An Automated Registration Algorithm for Measuring MRI Subcortical Brain Structures, NeuroImage, vol.6, issue.1, pp.13-25, 1997. ,
DOI : 10.1006/nimg.1997.0274
Enhancement of MR Images Using Registration for Signal Averaging, Journal of Computer Assisted Tomography, vol.22, issue.2, pp.324-357, 1998. ,
DOI : 10.1097/00004728-199803000-00032
Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space, Journal of Computer Assisted Tomography, vol.18, issue.2, pp.192-205, 1994. ,
DOI : 10.1097/00004728-199403000-00005
Unbiased average age-appropriate atlases for pediatric studies, NeuroImage, vol.54, issue.1, pp.313-340, 2011. ,
DOI : 10.1016/j.neuroimage.2010.07.033
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962759/pdf
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM), Philosophical Transactions of the Royal Society B: Biological Sciences, vol.356, issue.1412, 2001. ,
DOI : 10.1098/rstb.2001.0915
A quantitaive model for differential motility of gliomas in grey and white matter, pp.317-346, 2000. ,
Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation, IEEE Transactions on Medical Imaging, vol.24, issue.10, pp.1334-1380, 2005. ,
DOI : 10.1109/TMI.2005.857217
Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging, Magnetic Resonance in Medicine, vol.6, issue.3, pp.616-640, 2005. ,
DOI : 10.1016/S0002-9440(10)64183-1
Importance of patient DTI's to accurately model glioma growth using the reaction diffuse equation equation, ISBI, 2013. ,
Predicting the Location of Glioma Recurrence after a Resection Surgery, Medical Image Computing and Computer-Assisted Intervention, 2012. ,
DOI : 10.1007/978-3-642-33555-6_10
URL : https://hal.archives-ouvertes.fr/hal-00813870
The WHO Classification of Tumors of the Nervous System, Journal of Neuropathology & Experimental Neurology, vol.61, issue.3, pp.215-240, 2002. ,
DOI : 10.1093/jnen/61.3.215
Comparison of immunohistochemistry, DNA sequencing and allelespecific PCR for the detection of IDH1 mutations in gliomas, Int J Oncol, 2012. ,
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience, Journal of Neuro-Oncology, vol.47, issue.1, pp.85-91, 2013. ,
DOI : 10.1016/j.ejca.2010.11.031
Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA- methyltranferase in a series of 100 glioblastoma patients. Cancer, pp.4201-4212, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00667080
Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients, Journal of Neuro-Oncology, vol.124, issue.3, 2014. ,
DOI : 10.1007/s00401-012-1016-2
URL : https://hal.archives-ouvertes.fr/hal-00935512
Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas. Neuro-Oncol, pp.1379-88, 2013. ,
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients, Acta Neurochirurgica, vol.57, issue.7, 2007. ,
DOI : 10.1215/S1522851798000179
Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns, Journal of Neuro-Oncology, vol.12, issue.2, pp.179-85, 2006. ,
DOI : 10.1016/S0002-9440(10)64183-1
URL : https://hal.archives-ouvertes.fr/inserm-00147499
Glioblastoma survival in the United States before and during the temozolomide era, Journal of Neuro-Oncology, vol.25, issue.2, pp.359-64 ,
DOI : 10.1200/JCO.2007.12.2440
A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro- Oncol, pp.1178-84, 2012. ,
Long-term survival after the diagnosis of malignant glioma: A series of 22 patients surviving more than 4 years after diagnosis, Surgical Neurology, vol.38, issue.5, pp.359-63, 1992. ,
DOI : 10.1016/0090-3019(92)90022-F
Conditional probability of long-term survival in glioblastoma, Cancer, vol.30, issue.5, pp.5608-5621, 2012. ,
DOI : 10.1159/000115440
The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme, Journal of Neurosurgery, vol.101, issue.2, pp.219-245, 2004. ,
DOI : 10.3171/jns.2004.101.2.0219
Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer, pp.1745-1753, 2003. ,
Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM, PLoS ONE, vol.121, issue.1, p.16146, 2011. ,
DOI : 10.1371/journal.pone.0016146.s005
Dosedense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial, J Clin Oncol Off J Am Soc Clin Oncol, issue.32, pp.314085-91, 2013. ,
Transcriptional diversity of long-term glioblastoma survivors. Neuro-Oncol, pp.1186-95, 2014. ,
The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis, Familial Cancer, vol.19, issue.6, 2013. ,
DOI : 10.1097/CCO.0b013e3282f075f3
IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis, Tumor Biology, vol.29, issue.6, 2013. ,
DOI : 10.1007/s10014-012-0090-4
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling, International Journal of Cancer, vol.31, issue.Suppl 5, pp.1822-1853, 2014. ,
DOI : 10.1200/JCO.2013.49.6968
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients, PLOS ONE, vol.12, issue.7, p.130596, 2015. ,
DOI : 10.1371/journal.pone.0130596.t004
URL : https://hal.archives-ouvertes.fr/hal-01305489
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone, Neuro-Oncology, vol.16, issue.9, pp.1263-73, 2014. ,
DOI : 10.1093/neuonc/nou005
Gliomas: Survival, origin and early detection, Surgical Neurology International, vol.1, issue.1, p.96, 2010. ,
DOI : 10.4103/2152-7806.74243
URL : https://doi.org/10.4103/2152-7806.74243
Extrapolating glioma invasion margin in brain magnetic resonance images: Suggesting new irradiation margins, Medical Image Analysis, vol.14, issue.2, pp.111-136, 2010. ,
DOI : 10.1016/j.media.2009.11.005
URL : https://hal.archives-ouvertes.fr/inria-00616107
Image Guided Personalization of Reaction-Diffusion Type Tumor Growth Models Using Modified Anisotropic Eikonal Equations, IEEE Transactions on Medical Imaging, vol.29, issue.1, 2010. ,
DOI : 10.1109/TMI.2009.2026413
URL : https://hal.archives-ouvertes.fr/inria-00616100
Magnetic Resonance Imaging Characteristics of Glioblastoma Multiforme: Implications for Understanding Glioma Ontogeny, Neurosurgery, vol.67, issue.5, 2010. ,
DOI : 10.1227/NEU.0b013e3181f556ab
Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro-Oncol, pp.424-433, 2007. ,
Safety and Tumor Responses with Lambrolizumab (Anti???PD-1) in Melanoma, New England Journal of Medicine, vol.369, issue.2, pp.134-178, 2013. ,
DOI : 10.1056/NEJMoa1305133
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma, Neuro-Oncology, vol.17, issue.8, pp.1064-75, 2015. ,
DOI : 10.1093/neuonc/nou307
URL : https://academic.oup.com/neuro-oncology/article-pdf/17/8/1064/16856199/nou307.pdf
Imaging Surrogates of Infiltration Obtained Via Multiparametric Imaging Pattern Analysis Predict Subsequent Location of Recurrence of Glioblastoma, Neurosurgery, vol.78, issue.4, pp.572-80 ,
DOI : 10.1227/NEU.0000000000001202